In infants with Donohue syndrome and marked ovarian enlargement, GnRH analogues may be considered to prevent ovarian enlargement that in some cases is severe, while in young women with extreme IR and hyperandrogenism they may be used in combination with hormone replacement in a “block and replace” strategy when future fertility is desired. Here, GNRH1 is linked to Donohue syndrome.